Drug Profile
Naltrexone controlled-release - BioCorRx
Alternative Names: BICX101Latest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator Rainbow Biosciences; TheraKine
- Developer BioCorRx
- Class Anti-inflammatories; Antineoplastics; Antivirals; Cyclopropanes; Drug withdrawal therapies; Ethers; Eye disorder therapies; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alcoholism; Opioid-related disorders
Most Recent Events
- 28 May 2022 No recent reports of development identified for preclinical development in Alcoholism in USA (IM, Injection)
- 28 May 2022 No recent reports of development identified for preclinical development in Opioid-related-disorders in USA (IM, Injection)
- 30 Mar 2020 Preclinical development for Alcoholism is ongoing in USA